George Demetri
Quick Family Chair in Medical Oncology · Mass General Brigham
Credentials: · · · ·
History
- Present
- Present
Chan School of Public Health
Research
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
New England Journal of Medicine · 2002 · First of 21 authors · 3,431 citations
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children
New England Journal of Medicine · 2018 · 2,193 citations
The Lancet · 2006 · First of 17 authors · Corresponding · 2,046 citations
53 papers
53 papers · 1 as a fellow
- CF
46 papers
43 papers
- RM
39 papers
- MH
37 papers
- CC
29 papers
28 papers · 1 as a fellow
Grants
- 2007–2013
Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer
National Cancer Institute · P50
Project lead · $1M · Dana-Farber Cancer Inst
Clinical trials
- 2008–2009
Principal investigator · Terminated · Phase 3
Infinity Pharmaceuticals, Inc.
- 2005–2010
Principal investigator · Completed · Phase 1
Infinity Pharmaceuticals, Inc.
- 2000–2014
Principal investigator · Terminated · Phase 3
National Cancer Institute (NCI)
- 2006–2012
S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
Study chair · Completed · Phase 2
National Cancer Institute (NCI)